1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The pimavanserin market is witnessing pivotal momentum as neuropsychiatric care models evolve toward targeted, patient-centric solutions. For senior decision-makers, recognizing the shift from conventional antipsychotic strategies to innovative therapies like pimavanserin is critical to capitalizing on new opportunities, mitigating supply challenges, and optimizing patient outcomes in a rapidly shifting landscape.
Market Snapshot: Growth Trends and Strategic Positioning
Pimavanserin has emerged as a trailblazing antipsychotic, offering a unique serotonergic mechanism of action while minimizing disruption of dopaminergic pathways. Its initial approval for Parkinson disease psychosis catalyzed interest across clinical and research communities. The market is defined by increasing clinical adoption, expanding indications into Alzheimer disease psychosis and refractory schizophrenia, and recalibrated care standards. Regulatory bodies worldwide are updating frameworks to reflect the therapy’s differentiated clinical profile, while payers adjust reimbursement models in tandem with new outcome measures. Leading organizations are strategically reinforcing supply chain resilience in anticipation of shifting global trade dynamics.
Scope & Segmentation of the Pimavanserin Market
This report provides a multidimensional analysis of the pimavanserin market, examining demand, distribution, and adoption across several key segments and geographies:
- Indications: Alzheimer disease psychosis, Parkinson disease psychosis, schizophrenia.
- Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy.
- End Users: Homecare agencies, hospitals, specialty clinics.
- Patient Age Groups: Adult, elderly.
- Dosage Forms: Oral tablet 17 mg, oral tablet 34 mg.
- Regions Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering major markets such as United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (including China, India, Japan, Australia, among others).
- Leading Companies: ACADIA Pharmaceuticals, Teva Pharmaceutical Industries, Sandoz International GmbH, Mylan N.V., Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, Aurobindo Pharma, Hetero Drugs, Zydus Lifesciences, and Lupin Limited.
Key Takeaways for Senior Stakeholders
- Pimavanserin’s entry is facilitating a shift away from traditional side-effect profiles, driving multi-disciplinary collaboration across neurology and psychiatry.
- Evolving regulatory frameworks prioritize serotonergic modulation, encouraging innovative trial endpoints and adaptive protocols for future indications.
- Emerging real-world evidence complements controlled trial data, solidifying confidence in long-term clinical and economic outcomes.
- Growth in homecare and specialty clinic uptake underscores the need for personalized engagement models and clear titration guidelines for diverse patient populations.
- Strategic alliances and licensing agreements are shaping the competitive landscape, supporting R&D and market penetration for both current and pipeline therapies.
- Regional adoption nuances necessitate tailored go-to-market frameworks, aligning evidence generation and stakeholder outreach with local clinical and policy ecosystems.
Tariff Impact: Navigating Global Supply Challenges
The United States’ 2025 tariff regime has introduced new complexities for pimavanserin manufacturers. Increased duties on chemical inputs are influencing cost structures, prompting manufacturers to evaluate vertical integration and diversify supply portfolios. Innovative contracting with CDMOs, localization of secondary activities to low-duty regions, and enhanced inventory management strategies have become vital to maintaining pricing and ensuring uninterrupted patient access.
Methodology & Data Sources
This analysis integrates primary insights from expert consultations alongside secondary research, encompassing peer-reviewed literature, regulatory filings, healthcare databases, and competitive intelligence sources. Qualitative techniques such as thematic coding and scenario planning ensure a robust, multi-faceted perspective across all market variables.
Why This Report Matters: Actionable Market Intelligence
- Support critical decision-making by revealing actionable strategies to navigate evolving regulatory landscapes and optimize market access.
- Equip executives with up-to-date analysis on competitive movements, tariff impacts, and emerging therapy opportunities to sustain growth.
- Enable precise targeting of investment and partnership initiatives by providing segmented intelligence on regions, end users, and patient populations.
Conclusion
Pimavanserin is redefining standards for psychosis management by driving innovation across clinical, supply chain, and partnership models. Informed, agile strategies are essential for leaders to capture value and advance patient-centric outcomes in this changing market context.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of pimavanserin as a potential treatment in Alzheimer disease psychosis with supportive phase II trial data
5.2. FDA review timeline acceleration for pimavanserin extended indications under priority review pathways
5.3. Increased competition from biosimilar and generic pimavanserin formulations impacting pricing strategies
5.4. Strategic partnerships between biopharma companies and contract manufacturers to scale pimavanserin production capacity
5.5. Real world evidence studies highlighting long term safety and tolerability of pimavanserin in diverse patient populations
5.6. Expansion of patient access programs and specialty pharmacy distribution for pimavanserin in underserved regions
5.7. Digital therapeutics integration with pimavanserin treatment regimens to monitor patient adherence and response outcomes
5.8. Emerging pharmacoeconomic assessments demonstrating cost effectiveness of pimavanserin in neuropsychiatric disorders
5.9. Implementation of telehealth enabled prescribing models to streamline pimavanserin therapy initiation and follow up
5.2. FDA review timeline acceleration for pimavanserin extended indications under priority review pathways
5.3. Increased competition from biosimilar and generic pimavanserin formulations impacting pricing strategies
5.4. Strategic partnerships between biopharma companies and contract manufacturers to scale pimavanserin production capacity
5.5. Real world evidence studies highlighting long term safety and tolerability of pimavanserin in diverse patient populations
5.6. Expansion of patient access programs and specialty pharmacy distribution for pimavanserin in underserved regions
5.7. Digital therapeutics integration with pimavanserin treatment regimens to monitor patient adherence and response outcomes
5.8. Emerging pharmacoeconomic assessments demonstrating cost effectiveness of pimavanserin in neuropsychiatric disorders
5.9. Implementation of telehealth enabled prescribing models to streamline pimavanserin therapy initiation and follow up
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Pimavanserin Drugs Market, by Indication
8.1. Introduction
8.2. Indication
8.2.1. Alzheimer Disease Psychosis
8.2.2. Parkinson Disease Psychosis
8.2.3. Schizophrenia
8.2. Indication
8.2.1. Alzheimer Disease Psychosis
8.2.2. Parkinson Disease Psychosis
8.2.3. Schizophrenia
9. Pimavanserin Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Pimavanserin Drugs Market, by End User
10.1. Introduction
10.2. Homecare Agencies
10.3. Hospitals
10.4. Specialty Clinics
10.2. Homecare Agencies
10.3. Hospitals
10.4. Specialty Clinics
11. Pimavanserin Drugs Market, by Patient Age Group
11.1. Introduction
11.2. Adult
11.3. Elderly
11.2. Adult
11.3. Elderly
12. Pimavanserin Drugs Market, by Dosage Form
12.1. Introduction
12.2. Oral Tablet
12.2.1. 17 Mg
12.2.2. 34 Mg
12.2. Oral Tablet
12.2.1. 17 Mg
12.2.2. 34 Mg
13. Americas Pimavanserin Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pimavanserin Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pimavanserin Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ACADIA Pharmaceuticals, Inc.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Sandoz International GmbH
16.3.4. Mylan N.V.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Dr. Reddy’s Laboratories Ltd.
16.3.7. Aurobindo Pharma Limited
16.3.8. Hetero Drugs Limited
16.3.9. Zydus Lifesciences Limited
16.3.10. Lupin Limited
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ACADIA Pharmaceuticals, Inc.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Sandoz International GmbH
16.3.4. Mylan N.V.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Dr. Reddy’s Laboratories Ltd.
16.3.7. Aurobindo Pharma Limited
16.3.8. Hetero Drugs Limited
16.3.9. Zydus Lifesciences Limited
16.3.10. Lupin Limited
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PIMAVANSERIN DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PIMAVANSERIN DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PIMAVANSERIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PIMAVANSERIN DRUGS MARKET: RESEARCHAI
FIGURE 26. PIMAVANSERIN DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. PIMAVANSERIN DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. PIMAVANSERIN DRUGS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PIMAVANSERIN DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PIMAVANSERIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PIMAVANSERIN DRUGS MARKET: RESEARCHAI
FIGURE 26. PIMAVANSERIN DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. PIMAVANSERIN DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. PIMAVANSERIN DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PIMAVANSERIN DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ALZHEIMER DISEASE PSYCHOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ALZHEIMER DISEASE PSYCHOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PARKINSON DISEASE PSYCHOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PARKINSON DISEASE PSYCHOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOMECARE AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOMECARE AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 17 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 17 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 34 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 34 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 94. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 95. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 96. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 97. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 98. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 99. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 110. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 111. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 112. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 171. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 184. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 185. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 194. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 195. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 198. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 213. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 226. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 227. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 240. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 283. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 294. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 295. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 296. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 311. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 320. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 321. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 322. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 323. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 324. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 325. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 334. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 335. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 336. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 337. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 338. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 339. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 342. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ALZHEIMER DISEASE PSYCHOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ALZHEIMER DISEASE PSYCHOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PARKINSON DISEASE PSYCHOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PARKINSON DISEASE PSYCHOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOMECARE AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOMECARE AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 17 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 17 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 34 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY 34 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PIMAVANSERIN DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 94. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 95. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 96. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 97. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 98. CANADA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 99. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 110. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 111. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 112. MEXICO PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 171. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 184. GERMANY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 185. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 194. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 195. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 196. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 197. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 198. FRANCE PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 213. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 226. ITALY PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 227. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 240. SPAIN PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 283. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 284. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 285. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 294. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 295. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 296. DENMARK PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 311. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 320. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 321. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 322. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 323. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 324. QATAR PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 325. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 334. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 335. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 336. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 337. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 338. FINLAND PIMAVANSERIN DRUGS MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 339. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 342. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN PIMAVANSERIN DRUGS MARKET SIZE
Samples
LOADING...
Companies Mentioned
The companies profiled in this Pimavanserin Drugs market report include:- ACADIA Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Aurobindo Pharma Limited
- Hetero Drugs Limited
- Zydus Lifesciences Limited
- Lupin Limited
